Subclinical Diabetes Confirmed by 75gm-OGTT Influence on the Prognosis of Decompensated Cirrhosis
NCT04828512 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1015
Last updated 2021-04-02
Summary
Disorders of glucose metabolism, such as impaired glucose intolerance (IGT) and diabetes mellitus (DM), frequently occur in cirrhosis. However, it has been underestimated when fasting plasma glucose (FPG) levels are considered. We aimed to evaluate who needs to be undertaken a 75-g oral glucose tolerance test (OGTT) to find underlying subclinical diabetes.
Conditions
Sponsors & Collaborators
-
Yonsei University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-01-02
- Primary Completion
- 2014-01-30
- Completion
- 2021-12-30
More Related Trials
-
Changes in Liver Fibrosis, Lipid Profile and Insulin Resistance in HCV Patients Who Received Antiviral Therapy
NCT03612973 ·Status: COMPLETED ·Phase: NA
-
Metabolic Syndrome and Non-alcoholic Fatty Liver During Pregnancy
NCT02276144 ·Status: UNKNOWN
-
Hepatic Sugar Metabolism Measured by PET/CT in Patients and Healthy Subjects
NCT01369979 ·Status: COMPLETED
-
Is Fat in the Liver a Marker of Post-Pregnancy Glycaemic Deterioration in Women With Gestational Diabetes?
NCT04362540 ·Status: ACTIVE_NOT_RECRUITING
-
Liver Diseases: Extracellular Vesicles as Biomarkers
NCT07185360 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Prospective Cohort Study of Association of Insulin Resistance/Steatosis With Hepatic Fibrosis in CHB and NAFLD
NCT02031913 ·Status: COMPLETED
-
Change of Glucose Metabolism and Fibrosis Markers in Patients With Hepatitis C Under Treatment With Antiviral Agents
NCT03908294 ·Status: COMPLETED
-
The Association With Peptic Ulcer Disease and Hepatic Vein Pressure Gradient
NCT01944878 ·Status: COMPLETED
-
Assessment of Nonalcoholic Fatty Liver Disease in Diabetic and Prediabetic Patients Using Noninvasive Methods.
NCT04553796 ·Status: UNKNOWN
-
Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome
NCT06519162 ·Status: RECRUITING
-
Is There a Relationship Between Uric Acid Level and Liver Fibrosis in Obese Patients
NCT07168551 ·Status: NOT_YET_RECRUITING
-
Decompensation of Cirrhosis and Iron Metabolism
NCT04807023 ·Status: UNKNOWN
-
Early Screening of Hepatocellular Carcinoma in Cirrhotic Patients: a Prospective Study
NCT00629421 ·Status: COMPLETED
-
Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH
NCT05120557 ·Status: UNKNOWN ·Phase: NA
-
HCC Surveillance: Comparison of Abbreviated Non-contrast MRI and Ultrasound Surveillance in Cirrhotic Patients With Suboptimal Ultrasound Visualisation
NCT04455932 ·Status: RECRUITING ·Phase: NA
-
: Identification of Non-alcoholic Steato-hepatitis Cases in a Sample of Type 2 Diabetes Patients, with a Disruption of the Liver Function Tests, At the Pointe-à-Pitre University Hospital
NCT06738810 ·Status: COMPLETED ·Phase: NA
-
Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease
NCT02060565 ·Status: RECRUITING
-
Prevalence of Colon Cancer in Pyogenic Liver Abscess
NCT02032914 ·Status: COMPLETED
-
Effect of Thyroid Disorders in Liver Diseases
NCT06071923 ·Status: NOT_YET_RECRUITING
-
Biomarkers in the Diagnosis and Prognosis of NAFLD
NCT06098417 ·Status: RECRUITING
-
Prospective Cohort Study in Patients With NAFLD
NCT00575133 ·Status: RECRUITING
-
Metabolic Syndrome and Long-term Survival Following Liver Resection
NCT05568576 ·Status: COMPLETED
-
Identification and Validation of Noninvasive Biomarkers of the Diagnosis and Severity of NASH in Type 2 Diabetics
NCT03634098 ·Status: COMPLETED ·Phase: NA
-
Liver Fibrosis in Peri-menopausal Women
NCT03602573 ·Status: UNKNOWN
-
ASSESSMENT OF SURGICAL RISK IN PATIENTS WITH CHRONIC LIVER DISEASE USING VOCAL PENN SCORE
NCT06227988 ·Status: RECRUITING